Clinical trial
The Efficacy of Lonsurf® (Trifluridine/Tipiracil) Plus Chemotherapy in Metastatic Colorectal Cancer: Multi-center Prospective Study in Taiwan
NCT06495463 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Lonsurf® (Trifluridine/Tipiracil) Plus Chemotherapy in Metastatic Colorectal Cancer: Multi-center Prospective Study in Taiwan
- Lead sponsor
- Chang Gung Memorial Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 19, 2022
- Completion date
- December 31, 2024
- Enrollment
- 97 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic colorectal cancer